Open Access

FLNC pathogenic variants in patients with various cardiomyopathies:prevalence and genotype-phenotype correlations

Congress Session

About the speaker

Doctor Flavie Ader

Hospital Pitie-Salpetriere, Paris (France)
0 follower

5 more presentations in this session

Comparison of long-term clinical course and outcome of MYBPC3 - versus MYH7 - related hypertrophic cardiomyopathy.

Speaker: Doctor C. Fumagalli (Florence, IT)

Thumbnail

Survival after septal myectomy in male and female patients with hypertrophic obstructive cardiomyopathy

Speaker: Mr R. Huurman (Rotterdam, NL)

Thumbnail

In a prospective randomized study in familial hypertrophic cardiomyopathy, metoprolol maintains exercise-performance, with lower myocardial oxygen-cost, and prevents deterioration in exercise-ability

Speaker: Professor I. Ostman-Smith (Goteborg, SE)

Thumbnail

Myocardial transit time (MTT) - a novel and easy-to-perform CMR parameter to assess microvascular disease.

Speaker: Mr G. Chatzantonis (Munster, DE)

Thumbnail

Characteristics and clinical significance of right ventricular involvement in patients with hypertrophic cardiomyopathy

Speaker: Doctor K. Choi (Seoul, KR)

Thumbnail

Access the full session

Clinical, imaging and genetic advances in hypertrophic cardiomyopathy

Speakers: Doctor F. Ader, Doctor C. Fumagalli, Mr R. Huurman, Professor I. Ostman-Smith, Mr G. Chatzantonis...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk